Table 2.
Characteristics of included subjects
| Indices | Control group (n = 357) | NAFLD group (n = 357) | P value |
|---|---|---|---|
| Gender (M/F) | 115/242 | 118/239 | 0.887 |
| Age (Years) | 55.12 ± 12.11 | 56.10 ± 11.34 | 0.134 |
| BMI (Kg/m2) | 21.44 ± 2.19 | 26.14 ± 2.77 | < 0.01 |
| Waistline (cm) | 75.24 ± 6.44 | 90.13 ± 5.41 | < 0.01 |
| Hips (cm) | 90.76 ± 6.09 | 99.11 ± 7.31 | < 0.01 |
| WHR | 0.82 ± 0.07 | 0.92 ± 0.09 | < 0.01 |
| SBP (mmHg) | 122.4 ± 13.5 | 136.1 ± 15.2 | < 0.01 |
| DBP (mmHg) | 77.5 ± 10.3 | 85.45 ± 11.5 | < 0.01 |
| FPG (mmol/L) | 5.6 ± 1.3 | 6.6 ± 1.5 | < 0.01 |
| AST (u/L) | 25.6 ± 9.3 | 34.1 ± 9.7 | < 0.01 |
| ALT (u/L) | 18.9 ± 8.8 | 33.2 ± 10.3 | < 0.01 |
| TG (mmol/L) | l.24 ± 0.80 | 2.20 ± 1.12 | < 0.01 |
| TC (mmol/L) | 5.33 ± 1.22 | 5.76 ± 1.24 | < 0.01 |
| HDL-C (mmol/L) | 1.55 ± 0.56 | 1.23 ± 0.40 | < 0.01 |
| LDL-C (mmol/L) | 2.64 ± 0.88 | 2.88 ± 0.97 | < 0.01 |
| Fasting insulin (mIU/L) | 6.12 ± 2.35 | 11.44 ± 7.21 | < 0.01 |
| High-sensitivity CRP (mg/L) | 2.44 ± 1.01 | 3.89 ± 1.32 | < 0.01 |